Español · Català · English
Regulatory information
quantusFLM 3.1 Released date: 16.10.2019 is a non-invasive,fast and easy-to-use fetal lung maturity test, based on the automatic analysis of an ultrasound image of fetus lungs. Neither amniotic fluid nor any biologic sample is required to perform this test. Just by the analysis of an ultrasound image, quantusFLM can provide reliable information about the lung maturity in few minutes and therefore about its risk of suffering neonatal repiratory morbidity.
quantusFLM 3.1 has CE mark according to European Directive MDD 93/42/CEE and 2007/47/CE of Medical Supplies.

quantusFLM 3.1 has been developed by Transmural Biotech S.L., a company specialized in developing medical technologies based on image processing techniques.

 Transmural Biotech S.L.  Beethoven 15, Floor 4, Office18, 08021 Barcelona, Spain.
© quantusFLM is the property of Transmural Biotech